Mapping N- to C-terminal allosteric coupling through disruption of a putative CD74 activation site in D-dopachrome tautomerase

J Biol Chem. 2023 Jun;299(6):104729. doi: 10.1016/j.jbc.2023.104729. Epub 2023 Apr 18.

Abstract

The macrophage migration inhibitory factor (MIF) protein family consists of MIF and D-dopachrome tautomerase (also known as MIF-2). These homologs share 34% sequence identity while maintaining nearly indistinguishable tertiary and quaternary structure, which is likely a major contributor to their overlapping functions, including the binding and activation of the cluster of differentiation 74 (CD74) receptor to mediate inflammation. Previously, we investigated a novel allosteric site, Tyr99, that modulated N-terminal catalytic activity in MIF through a "pathway" of dynamically coupled residues. In a comparative study, we revealed an analogous allosteric pathway in MIF-2 despite its unique primary sequence. Disruptions of the MIF and MIF-2 N termini also diminished CD74 activation at the C terminus, though the receptor activation site is not fully defined in MIF-2. In this study, we use site-directed mutagenesis, NMR spectroscopy, molecular simulations, in vitro and in vivo biochemistry to explore the putative CD74 activation region of MIF-2 based on homology to MIF. We also confirm its reciprocal structural coupling to the MIF-2 allosteric site and N-terminal enzymatic site. Thus, we provide further insight into the CD74 activation site of MIF-2 and its allosteric coupling for immunoregulation.

Keywords: NMR; allostery; cytokine; protein dynamics; receptor activation.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Antigens, Differentiation, B-Lymphocyte / metabolism
  • Binding Sites
  • Histocompatibility Antigens Class II / metabolism
  • Humans
  • Inflammation
  • Macrophage Migration-Inhibitory Factors* / metabolism

Substances

  • dopachrome isomerase
  • Macrophage Migration-Inhibitory Factors
  • Antigens, Differentiation, B-Lymphocyte
  • Histocompatibility Antigens Class II